4h
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insulins that are being discontinued and some are where there is a temporary shortage. Here’s the ...
There are currently shortages of the Fiasp FlexTouch insulin pen which could affect people living with diabetes who take Fiasp insulin. Here’s what you need to know.
The Samsung Galaxy S25 Ultra S Pen no longer supports Bluetooth connectivity, removing features like Air Actions. Samsung says the change was made due to low user engagement and suggests using ...
Prompted by Seldon's questioning, Krieger said the Humalog insulin, assuming that Michael only received one injection though at an unknown volume, would no longer be active in Michael's body by ...
The S Pen has been one of the standout features on Samsung flagships for many years. First integrated with the Note line, the S Pen is now a core part of the Galaxy S Ultra models, newer foldables ...
BECKLEY, W.Va. — A prosecution expert witness told a Raleigh County jury Tuesday that Michael Cochran suffered from hypoglycemia due from an insulin injection was a strong possibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results